Please login to the form below

Not currently logged in
Email:
Password:

ALK-Abello appoints Søren Jelert as CFO

He will be based at the company’s headquarters in Denmark

Soren JelertDansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees him succeed Flemming Pederson at the pharmaceutical company.

Jelert most recently served as a general manager for NNE, an engineering company that specialises in supporting pharmaceutical company engineering projects.

He said: “This new role offers me the opportunity to use my knowledge and experience to support and further develop ALK as it works to build a new growth platform and to become a truly global allergy company.”

His career has seen him serve in various capacities for Novo Nordisk, including as finance director Europe North and manager operations, finance.

Carsten Hellmann, president and chief executive officer, ALK, said: “Søren brings a wealth of experience to ALK, in particular from his previous pharmaceutical industry-focused roles at NNE and Novo Nordisk.

“He has a proven track record of financial leadership and he has also played a pivotal role in transformation processes that are comparable to the one we are embarking upon at ALK.”

Jelert will be based at ALK’s headquarters in Hørsholm, Denmark and will report directly to Hellmann.

11th December 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening...